Optimized lentiviral vector production and purification procedure prevents immune response after transduction of mouse brain.
about
Identification of protein phosphatase 1 as a regulator of the LRRK2 phosphorylation cycleIn vivo correction of ZAP-70 immunodeficiency by intrathymic gene transferAltering the tropism of lentiviral vectors through pseudotyping.Identification of unique reciprocal and non reciprocal cross packaging relationships between HIV-1, HIV-2 and SIV reveals an efficient SIV/HIV-2 lentiviral vector system with highly favourable features for in vivo testing and clinical usageProduction of lentiviral vectorsSelection of novel vesicular stomatitis virus glycoprotein variants from a peptide insertion library for enhanced purification of retroviral and lentiviral vectorsReporter gene-expressing bone marrow-derived stromal cells are immune-tolerated following implantation in the central nervous system of syngeneic immunocompetent mice.Simplified production and concentration of HIV-1-based lentiviral vectors using HYPERFlask vessels and anion exchange membrane chromatography.Immunohistochemical detection of transgene expression in the brain using small epitope tags.Gene delivery to the spinal cord: comparison between lentiviral, adenoviral, and retroviral vector delivery systemsLDLR-Gene therapy for familial hypercholesterolaemia: problems, progress, and perspectivesSimplified production and concentration of lentiviral vectors to achieve high transduction in primary human T cells.Chondroitinase activity can be transduced by a lentiviral vector in vitro and in vivo.Tackling Glaucoma from within the Brain: An Unfortunate Interplay of BDNF and TrkBLong-Term Fate Mapping Using Conditional Lentiviral Vectors Reveals a Continuous Contribution of Radial Glia-Like Cells to Adult Hippocampal Neurogenesis in Mice.Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production.Downstream processing of viral vectors and vaccines.The feasibility of incorporating Vpx into lentiviral gene therapy vectors."Marker of Self" CD47 on lentiviral vectors decreases macrophage-mediated clearance and increases delivery to SIRPA-expressing lung carcinoma tumorsHost SAMHD1 protein promotes HIV-1 recombination in macrophages.Lentiviral vectors and cystic fibrosis gene therapyEngineered T cell therapies.Assessment of selected media supplements to improve F/HN lentiviral vector production yields.The CRF family of neuropeptides and their receptors - mediators of the central stress response.NDRG4 is a novel oncogenic protein and p53 associated regulator of apoptosis in malignant meningioma cellsNDRG4, the N-Myc downstream regulated gene, is important for cell survival, tumor invasion and angiogenesis in meningiomas.Production of lentiviral vectors in protein-free media.COS-1 cells as packaging host for production of lentiviruses.Evaluation of the specificity and sensitivity of ferritin as an MRI reporter gene in the mouse brain using lentiviral and adeno-associated viral vectors.Production and purification of lentiviral vectors generated in 293T suspension cells with baculoviral vectors.High-titer lentiviral vectors stimulate fetal calf serum-specific human CD4 T-cell responses: implications in human gene therapy.In vivo IL13-primed macrophages contribute to reduced alloantigen-specific T cell activation and prolong immunological survival of allogeneic mesenchymal stem cell implants.Tubulovesicular structures within vesicular stomatitis virus G protein-pseudotyped lentiviral vector preparations carry DNA and stimulate antiviral responses via Toll-like receptor 9.CNS-targeted LIF expression improves therapeutic efficacy and limits autoimmune-mediated demyelination in a model of multiple sclerosis.In vivo evaluation of an EIAV vector for the systemic genetic delivery of therapeutic antibodies.Intracerebral transplantation of interleukin 13-producing mesenchymal stem cells limits microgliosis, oligodendrocyte loss and demyelination in the cuprizone mouse model.Interleukin-13 immune gene therapy prevents CNS inflammation and demyelination via alternative activation of microglia and macrophages.Lentiviral Transduction of Neurons in Adult Brain: Evaluation of Inflammatory Response and Cognitive Effects in Mice.Evaluation of the expression pattern of rAAV2/1, 2/5, 2/7, 2/8, and 2/9 serotypes with different promoters in the mouse visual cortex.Distinct spatial distribution of microglia and macrophages following mesenchymal stem cell implantation in mouse brain.
P2860
Q24317158-F7EE5E99-5387-4C74-93B0-9BED879B3574Q24532255-35B78204-856F-481C-A1AC-B627F1FC1BE7Q24538987-38EACC80-7752-4C0F-8678-AB43CA1F143BQ24810805-D44E2081-AE60-4990-BC1B-CBA2FBC60106Q26750586-0BF02740-93E4-4BF5-B1C4-D08BADE82EA6Q33236504-20E2FDC3-C046-4A08-9E4D-B34F736E4A85Q33398144-8A2F401F-605D-4EEF-BE3D-768B49BC5452Q33409769-AA9DA5EC-5683-4D20-8E3A-C5505189DA0CQ33532297-B04C9657-7AAA-4880-829C-CF2D4A101BFAQ33821596-A79077CF-3C8F-4033-8AE8-1603132BE0AFQ34467839-A63D2D5E-CB18-4DE7-BC4C-52946AED4A0BQ35038348-8024E0A9-F9E7-4ABD-A2BA-1F8387A43A64Q35112769-B0C12735-B148-41E7-A0D8-E4C0C6ADF921Q35839275-98748021-615C-4AC2-A72A-29BBD856AD74Q35850836-75CFCAD4-FBE0-4620-A4E2-96873F7DDF0DQ36186475-AED7D553-75D6-435F-853B-EC64EBC64E55Q36288881-167C9298-EF08-408C-B7BF-7954382C89BBQ37350713-D49CAB7D-8444-41C9-AD2E-7A7511653256Q37490583-45AF17F8-7D61-4EE7-BE66-A33D201D7494Q37536426-82E4B54E-DF57-4A6A-BDB4-EA25BFC0C358Q38614351-D64AEF59-C6FE-4DB6-A0A7-765172E5A4D4Q38623827-AA619E42-3EAE-40A8-A4DA-7798915660CDQ38693642-B874148F-B600-46CC-A1C8-48129A587FACQ38750612-86A0766A-0195-46FD-9D61-63BC6272D388Q38866385-9A0B151C-818F-4EF4-9A54-8FF5E0483B54Q39301482-17C29651-1F5C-481C-B598-BFAF3654954DQ39576640-02F4D592-5057-473F-A055-8A1B30D3CCD9Q39576647-9DE2B122-4E20-4E61-A488-03C0BDC091C0Q39586854-BD3A760F-4C01-4DA6-B234-8D5A4F2FFC0FQ39605476-E7E6CCC3-519F-4FBE-A8E2-299D677F94C8Q39865119-AE4C5B06-9E00-4D78-9ACB-FAD867C4FD78Q39908369-77FC0CB8-EC97-4B72-935C-BC8B57EB228DQ40213297-1A311576-4322-4DED-A547-D0C3327B7AD8Q40295296-BAF1772B-379B-4400-959B-23448E302861Q40445773-5004DA0B-EA17-4B5C-B4B7-79E42CB3366AQ40458129-123363FB-F92C-413A-872C-FCB333A3E54BQ40499853-7E208B8E-B5E8-4281-B691-8AD92A215E42Q40665249-CD7543E6-21E4-4CE9-AC37-7DE8DF1B0203Q41716240-DCA2E1E9-42BF-40A0-BA93-6FBB686E5BC0Q42208013-B5D47286-F002-46C7-BB73-6BE03A5EE6BF
P2860
Optimized lentiviral vector production and purification procedure prevents immune response after transduction of mouse brain.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Optimized lentiviral vector pr ...... r transduction of mouse brain.
@en
type
label
Optimized lentiviral vector pr ...... r transduction of mouse brain.
@en
prefLabel
Optimized lentiviral vector pr ...... r transduction of mouse brain.
@en
P2093
P2860
P356
P1433
P1476
Optimized lentiviral vector pr ...... r transduction of mouse brain.
@en
P2093
Baekelandt V
Eggermont K
Michiels M
P2860
P2888
P304
P356
10.1038/SJ.GT.3302094
P577
2003-11-01T00:00:00Z
P5875
P6179
1036280227